| ZHANG N G, PATI D. Sororin is a Master Regulator of Sister Chromatid Cohesion and Separation[J]. Cell Cycle, 2012, 11(11): 2073-2083. doi: 10.4161/cc.20241 |
| RANKIN S, AYAD N G, KIRSCHNER M W. Sororin, a Substrate of the Anaphase-Promoting Complex, is Required for Sister Chromatid Cohesion in Vertebrates[J]. Molecular Cell, 2005, 18(2): 185-200. doi: 10.1016/j.molcel.2005.03.017 |
| FU G H, XU Z J, CHEN X Y, et al. CDCA5 Functions as a Tumor Promoter in Bladder Cancer by Dysregulating Mitochondria-Mediated Apoptosis, Cell Cycle Regulation and PI3k/AKT/mTOR Pathway Activation[J]. Journal of Cancer, 2020, 11(9): 2408-2420. doi: 10.7150/jca.35372 |
| CHEN H, CHEN J, ZHAO L, et al. CDCA5, Transcribed by E2F1, Promotes Oncogenesis by Enhancing Cell Proliferation and Inhibiting Apoptosis via the AKT Pathway in Hepatocellular Carcinoma[J]. Journal of Cancer, 2019, 10(8): 1846-1854. doi: 10.7150/jca.28809 |
| CAI C Z, WANG W L, TU Z H. Aberrantly DNA Methylated-Differentially Expressed Genes and Pathways in Hepatocellular Carcinoma[J]. Journal of Cancer, 2019, 10(2): 355-366. doi: 10.7150/jca.27832 |
| ZHANG Z Y, SHEN M Y, ZHOU G R. Upregulation of CDCA5 Promotes Gastric Cancer Malignant Progression via Influencing Cyclin E1[J]. Biochemical and Biophysical Research Communications, 2018, 496(2): 482-489. doi: 10.1016/j.bbrc.2018.01.046 |
| HUANG J B, LI Y, LU Z L, et al. Analysis of Functional Hub Genes Identifies CDC45 as an Oncogene in Non-small Cell Lung Cancer-a Short Report[J]. Cellular Oncology (Dordrecht), 2019, 42(4): 571-578. |
| SAITO Y, KOYA J, KATAOKA K. Multiple Mutations within Individual Oncogenes[J]. Cancer Science, 2021, 112(2): 483-489. doi: 10.1111/cas.14699 |
| LAMBERT A W, PATTABIRAMAN D R, WEINBERG R A. Emerging Biological Principles of Metastasis[J]. Cell, 2017, 168(4): 670-691. doi: 10.1016/j.cell.2016.11.037 |
| CELIÀ-TERRASSA T, KANG Y B. Metastatic Niche Functions and Therapeutic Opportunities[J]. Nature Cell Biology, 2018, 20(8): 868-877. doi: 10.1038/s41556-018-0145-9 |
| HUI L L, CHEN Y. Tumor Microenvironment: Sanctuary of the Devil[J]. Cancer Letters, 2015, 368(1): 7-13. doi: 10.1016/j.canlet.2015.07.039 |
| PITT J M, MARABELLE A, EGGERMONT A, et al. Targeting the Tumor Microenvironment: Removing Obstruction to Anticancer Immune Responses and Immunotherapy[J]. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 2016, 27(8): 1482-1492. doi: 10.1093/annonc/mdw168 |
| 王苗, 张国洪. 考虑化疗、免疫治疗及分布时滞的肿瘤动力学模型[J]. 西南师范大学学报(自然科学版), 2021, 46(1): 153-159. |
| TOMCZAK K, CZERWIŃSKA P, WIZNEROWICZ M. The Cancer Genome Atlas (TCGA): an Immeasurable Source of Knowledge[J]. Contemporary Oncology, 2015, 19(1A): A68-A77. |
| CONSORTIUM G. The Genotype-tissue Expression (GTEx) Project[J]. Nature Genetics, 2013, 45(6): 580-585. doi: 10.1038/ng.2653 |
| LI B, SEVERSON E, PIGNON J C, et al. Comprehensive Analyses of Tumor Immunity: Implications for Cancer Immunotherapy[J]. Genome Biology, 2016, 17(1): 174. doi: 10.1186/s13059-016-1028-7 |
| LI T W, FAN J Y, WANG B B, et al. TIMER: a Web Server for Comprehensive Analysis of Tumor-infiltrating Immune Cells[J]. Cancer Research, 2017, 77(21): 108-110. doi: 10.1158/0008-5472.CAN-17-0307 |
| LIU C J, HU F F, XIA M X, et al. GSCALite: a Web Server for Gene Set Cancer Analysis[J]. Bioinformatics, 2018, 34(21): 3771-3772. doi: 10.1093/bioinformatics/bty411 |
| KANEHISA M, SATO Y, FURUMICHI M, et al. New Approach for Understanding Genome Variations in KEGG[J]. Nucleic Acids Research, 2019, 47(D1): 590-595. doi: 10.1093/nar/gky962 |
| LADURNER R, KREIDL E, IVANOV M P, et al. Sororin Actively Maintains Sister Chromatidcohesion[J]. The EMBO Journal, 2016, 35(6): 635-653. doi: 10.15252/embj.201592532 |
| NISHIYAMA T, SYKORA MM, HUIS IN 'T VELD P J, et al. Aurora B and Cdk1 Mediate Wapl Activation and Release of Acetylated Cohesin from Chromosomes by Phosphorylating Sororin[J]. Proceedings of the National Academy of Sciences of the United States of America, 2013, 110(33): 13404-13409. |
| ZHOU Q, REN J B, HOU J X, et al. Co-expression Network Analysis Identified Candidate Biomarkers in Association with Progression and Prognosis of Breast Cancer[J]. Journal of Cancer Research and Clinical Oncology, 2019, 145(9): 2383-2396. doi: 10.1007/s00432-019-02974-4 |
| FU Y, ZHOU Q Z, ZHANG X L, et al. Identification of Hub Genes Using Co-expression Network Analysis in Breast Cancer as a Tool to Predict Different Stages[J]. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 2019, 25: 8873-8890. |
| PHAN NN, WANG C Y, LI K L, et al. Distinct Expression of CDCA3, CDCA5, and CDCA8 Leads to Shorter Relapse Free Survival in Breast Cancer Patient[J]. Oncotarget, 2018, 9(6): 6977-6992. doi: 10.18632/oncotarget.24059 |
| NISHIYAMA T, LADURNER R, SCHMITZ J, et al. Sororin Mediates Sister Chromatid Cohesion by Antagonizing Wapl[J]. Cell, 2010, 143(5): 737-749. doi: 10.1016/j.cell.2010.10.031 |
| ZHANG N G, PATI D. C-terminus of Sororin Interacts with SA2 and Regulates Sister Chromatid Cohesion[J]. Cell Cycle, 2015, 14(6): 820-826. doi: 10.1080/15384101.2014.1000206 |
| Evan G I, Vousden K H. Proliferation, Cell Cycle and Apoptosis in Cancer[J]. Nature, 2001, 411(6835): 342-348. doi: 10.1038/35077213 |
| BORTON M T, RASHID M S, DREIER M R, et al. Multiple Levels of Regulation of Sororin by Cdk1 and Aurora B[J]. Journal of Cellular Biochemistry, 2016, 117(2): 351-360. doi: 10.1002/jcb.25277 |
| BECHT E, GIRALDO N A, DIEU-NOSJEAN M C, et al. Cancer Immune Contexture and Immunotherapy[J]. Current Opinion in Immunology, 2016, 39: 7-13. doi: 10.1016/j.coi.2015.11.009 |
| MIKAMI S, MIZUNO R, KONDO T, et al. Clinical Significance of Programmed Death-1 and Programmed Death-Ligand 1 Expression in the Tumor Microenvironment of Clear Cell Renal Cell Carcinoma[J]. Cancer Science, 2019, 110(6): 1820-1828. doi: 10.1111/cas.14019 |